Flask Co., Ltd. Share Price

Equities

A041590

KR7041590001

Home Improvement Products & Services Retailers

End-of-day quote Korea S.E. 23:00:00 27/03/2024 GMT 5-day change 1st Jan Change
789 KRW +13.69% Intraday chart for Flask Co., Ltd. -.--% -21.10%

Financials

Sales 2022 39.67B 28.84M 2.31B Sales 2023 22.76B 16.55M 1.32B Capitalization 132B 95.67M 7.66B
Net income 2022 -22.56B -16.4M -1.31B Net income 2023 -37.53B -27.28M -2.18B EV / Sales 2022 3.65 x
Net Debt 2022 2.43B 1.76M 141M Net Debt 2023 23.11B 16.8M 1.35B EV / Sales 2023 6.8 x
P/E ratio 2022
-5.9 x
P/E ratio 2023
-3.48 x
Employees 138
Yield 2022 *
-
Yield 2023
-
Free-Float 60.34%
More Fundamentals * Assessed data
Dynamic Chart
Flask Co., Ltd. cancelled the transaction announced on March 13, 2024 CI
Motiva Korea Ltd. cancelled the acquisition of 9.5% stake in Flask Co., Ltd. from B&M Holdings. CI
Motiva Korea Ltd. agreed to acquire 9.5% stake in Flask Co., Ltd. from B&M Holdings for KRW 17.6 billion. CI
Flask Co., Ltd. announced that it expects to receive KRW 14.9999994 billion in funding CI
Flask Co., Ltd.(KOSDAQ:A041590) dropped from S&P Global BMI Index CI
NEXTURNBIOSCIENCE Co., Ltd. announced that it has received KRW 7 billion in funding from Flask Co., Ltd., GLK Equity Investment Co., Ltd., SAMSUNG PHARM. Co., LTD., CMG Pharmaceutical Co., Ltd. CI
NEXTURNBIOSCIENCE Co., Ltd. announced that it expects to receive KRW 9 billion in funding from Flask Co., Ltd., GLK Equity Investment Co., Ltd., SAMSUNG PHARM. Co., LTD., CMG Pharmaceutical Co., Ltd. CI
FLASK to Unveil the Beta Version of Its Web 3.0 GameFi Platform NAODA for Global Access CI
Flask Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Flask Co., Ltd.(KOSDAQ:A041590) added to S&P Global BMI Index CI
Gemvaxzio Co., Ltd. announced that it expects to receive KRW 30 billion in funding CI
Gemvaxzio Co., Ltd. announced that it expects to receive KRW 54.999999102 billion in funding from B&M Holdings Inc. and another investor CI
Gemvaxzio Co., Ltd. announced that it has received KRW 7.3 billion in funding from SAMSUNG PHARM. Co., LTD. CI
GemVax&KAEL Co.,Ltd acquired additional 12.99% stake in Gemvaxzio Co., Ltd. for KRW 18.02 billion. CI
Gemvaxzio Co., Ltd. announced that it has received KRW 12.8 billion in funding CI
More news
1 day+13.69%
1 month+5.20%
3 months-17.47%
6 months-45.32%
Current year-21.10%
More quotes
1 month
718.00
Extreme 718
793.00
Current year
592.00
Extreme 592
1 375.00
1 year
592.00
Extreme 592
1 480.00
3 years
592.00
Extreme 592
2 900.00
5 years
589.00
Extreme 589
2 900.00
10 years
589.00
Extreme 589
16 800.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 54 -
Chief Executive Officer 54 -
Chief Executive Officer 57 29/04/13
Members of the board TitleAgeSince
Chief Executive Officer 57 29/04/13
Director/Board Member 48 07/03/22
Director/Board Member 44 -
More insiders
Flask Co Ltd, formerly Gemvaxzio Co Ltd, is a Korea-based company engaged in the interior business. The Company operates its business through three segments. The Interior Business segment is involved in the businesses of interior design and construction, such as furniture design, manufacture and installation, as well as architectural design and construction. The Energy Business segment mainly engages in the construction of renewable energy devices and facilities, such as ice thermal storage cooling systems and electricity storage systems (ESSs). The Leasing Business segment mainly engages in the leasing of shops.
More about the company
  1. Stock Market
  2. Equities
  3. A041590 Stock